Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Faron BEXMAB Phase II study results

By Inderes
Faron Pharmaceuticals

Faron will be hosting a virtual webinar to discuss the full analysis of r/r MDS as well as new frontline HR MDS patient data on Monday, 2 June 2025.

Stay up to date
Investor events

Recent videos

Green Landscaping Group, Audiocast, Q4'25
28.01.2026, 12.00 Green Landscaping Group
HCA Morgenbørs 28/01 - Fokus på aftenens rentemøde og de første regnskaber fra Magnificent 7-aktierne
28.01.2026, 09.18 GreenMobility
Atlas Copco Group, Audiocast, Q4'25
27.01.2026, 14.00 Atlas Copco
Xvivo, Audiocast, Q4'25
27.01.2026, 14.00 Xvivo Perfusion
Getinge, Audiocast, Q4'25
27.01.2026, 10.00 Getinge
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.